文献速递肝病

美国酒精性肝病流行病学:三大数据库回顾性分析

Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

该研究利用美国NHANES、NIS和UNOS三个数据库回顾性分析酒精性肝病(ALD)流行病学。结果显示ALD总体患病率稳定,但晚期纤维化比例、肝硬化住院及肝移植等待名单人数显著增加,提示疾病严重程度上升。

要点

  • ALD总体患病率稳定,但晚期纤维化(≥3期)比例从2.2%升至6.6%。
  • 酒精性肝硬化住院率增加32.8%,≥3种并发症比例从11.6%升至25.8%。
  • ALD肝移植等待名单人数增加63.4%,合并肝细胞癌比例增加178%。

核心结论

  • 三个美国数据库一致显示ALD严重程度增加,需加强酒精使用障碍的干预。

研究设计与样本

  • 回顾性观察性研究,使用2001-2016年NHANES、2007-2014年NIS和2007-2017年UNOS数据库分析美国成人ALD。

主要发现

  • NHANES中ALD总体加权患病率从8.8%变为8.1%(P=0.102),但≥3期纤维化比例从2.2%(95%CI:0.4-4.0)升至6.6%(95%CI:2.0-9.9;P=0.007)。
  • NIS中酒精性肝硬化住院率每1000人增加32.8%,≥3种肝硬化并发症的住院比例从11.6%(2007年)升至25.8%(2014年)(Ptrend<0.0001)。
  • UNOS中ALD肝移植等待名单成人总数增加63.4%,合并肝细胞癌比例增加178%。

关键数值与推荐

  • NHANES中ALD定义基于临床实验室数据和自我报告的酒精使用,纤维化-4评分>2.67定义为≥3期纤维化。
  • NIS中酒精性肝硬化通过国际疾病分类第九版代码识别。
  • UNOS中ALD通过UNOS编码识别。

临床怎么用

  • 临床应关注ALD患者晚期纤维化的筛查与评估。
  • 对酒精使用障碍患者需加强干预以延缓疾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Alcoholic liver disease (ALD) prevalence, particularly the subset with advanced liver disease, is not well defined. Herein, we aim to provide a comprehensive assessment of ALD epidemiology across the spectrum of disease severity and across different settings using 3 unique US databases. METHODS: We performed a retrospective, observational study of US adults with ALD using 2001-2016 National Health and Nutrition Examination Survey (NHANES), 2007-2014 Nationwide Inpatient Sample (NIS), and 2007-2017 United Network for Organ Sharing (UNOS) registry. ALD in the NHANES was defined using clinical laboratory data and self-reported alcohol use, among which fibrosis-4 score of >2.67 defined stage ≥3 fibrosis. Alcoholic cirrhosis (AC) in the NIS was identified using International Classification of Diseases, Ninth Revision codes. ALD in the UNOS was identified using UNOS coding. RESULTS: From 2001-2002 to 2015-2016, the overall weighted ALD prevalence was stable from 8.8% to 8.1% (P = 0.102), whereas the proportion of ALD with stage ≥3 fibrosis increased from 2.2% (95% CI: 0.4-4.0) to 6.6% (95% CI: 2.0-9.9; P = 0.007) (NHANES). From 2007 to 2014, the number of hospitalizations among patients with AC per 1,000 increased by 32.8%, and the proportion of hospitalizations among the patients with AC with ≥3 cirrhosis complications increased from 11.6% in 2007 to 25.8% in 2014 (Ptrend < 0.0001) (NIS). From 2007 to 2017, the total number of adults with ALD listed for liver transplant increased by 63.4% and the proportion with concurrent hepatocellular carcinoma increased by 178% (UNOS). DISCUSSION: Among these 3 US databases, consistent observations of increasing ALD severity emphasize the urgent need for greater awareness about the consequences of unhealthy alcohol use and interventions aimed specifically at addressing alcohol use disorders.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Dang K, Hirode G, Singal AK, et al. Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases. Am J Gastroenterol. 2020. PMID: 31517639. doi:10.14309/ajg.0000000000000380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。